NASDAQ:TPST | Free Cash Flow | Tempest Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-06-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$7.6M$0.00-$7.6M
2025-12-31-$3.57M$0.00-$3.57M
2025-03-31-$8.04M$0.00-$8.04M
2024-12-31-$10.15M$3,000.00-$10.15M
2024-03-31-$7.19M$168,000.00-$7.35M
2023-12-31-$6.18M$7,000.00-$6.18M
2023-03-31-$8.3M$46,000.00-$8.35M
2022-12-31-$6.48M$356,000.00-$6.84M
2022-03-31-$7.11M$3,000.00-$7.11M
2021-12-31-$7.99M$27,000.00-$8.01M
2021-03-31-$6.31M$14,000.00-$6.32M
2020-12-31-$4.27M$5,000.00-$4.28M
2020-03-31-$10.16M$26,000.00-$10.19M
2019-12-31-$11.69M$33,000.00-$11.72M
2019-03-31-$10.6M$10,000.00-$10.61M
2018-12-31-$9.23M$16,000.00-$9.24M
2018-03-31-$5M$1,000.00-$5M
2017-12-31$17.24M-$108,000.00$17.13M
2017-03-31-$15.19M$75,000.00-$15.26M
2016-12-31-$14.97M$1.54M-$16.51M
2016-03-31-$15.41M$370,000.00-$15.78M
2015-12-31-$11.32M$2.91M-$14.23M
2015-03-31-$14.39M$389,000.00-$14.78M
2014-12-31-$10.52M$1.34M-$11.86M
2014-03-31-$4.96M
2013-12-31-$4.69M$212,000.00-$4.9M
2013-03-31-$4.06M$184,000.00-$4.24M
2012-12-31-$3.48M$145,000.00-$3.63M
2012-03-31-$818,000.00$431,000.00-$1.25M
2011-06-30$5,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$26.82M$0.00-$26.82M
2024-12-31-$33.03M$435,000.00-$33.46M
2023-12-31-$27.36M$170,000.00-$27.53M
2022-12-31-$31.07M$562,000.00-$31.63M
2021-12-31-$25.96M$135,000.00-$26.09M
2020-12-31-$19.02M$50,000.00-$19.07M
2019-12-31-$41.22M$397,000.00-$41.62M
2018-12-31-$23.65M$36,000.00-$23.68M
2017-12-31-$20.34M$4,000.00-$20.34M
2016-12-31-$61.73M$2.59M-$64.32M
2015-12-31-$50.29M$5.23M-$55.52M
2014-12-31-$30.59M$2.8M-$33.39M
2013-12-31-$18.09M$719,000.00-$18.81M
2012-12-31-$11.16M$849,000.00-$12.01M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.